Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis

被引：0
|
作者：
Radwa El Borolossy
Lamia Mohamed El Wakeel
Ihab El Hakim
Nagwa Sabri
机构：
[1] Ain Shams University,Department of Clinical Pharmacy, Faculty of Pharmacy
[2] Ain Shams University,Department of Pediatrics, Faculty of Medicine
来源：
Pediatric Nephrology | 2016年 / 31卷
关键词：
Pediatric patients; Hemodialysis; Nicotinamide; Hyperphosphatemia; Lipid profile;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：289 / 296
页数：7
相关论文
共 50 条
  • [21] Use of nicotinamide to treat hyperphosphatemia in dialysis patients
    Lenglet A.
    Liabeuf S.
    Guffroy P.
    Fournier A.
    Brazier M.
    Massy Z.A.
    Drugs in R&D, 2013, 13 (3) : 165 - 173
  • [22] Safety and efficacy of PCNL for management of staghorn calculi in pediatric patients
    Kumar, Rajeev
    Anand, Ajay
    Saxena, Vaibhav
    Seth, Amlesh
    Dogra, Prem Nath
    Gupta, Narmada P.
    JOURNAL OF PEDIATRIC UROLOGY, 2011, 7 (03) : 248 - 251
  • [23] Efficacy of a nonabsorbable phosphate binder for the treatment of hyperphosphatemia in chronic hemodialysis patients.
    Reiner, D
    Kern, M
    Burke, S
    Wilkes, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2636 - A2636
  • [24] EFFICACY AND SAFETY OF DENOSUMAB IN HEMODIALYSIS PATIENTS
    Tanigawa, H.
    Tamagawa, Y.
    Tanemura, M.
    Nakajima, R.
    Imai, S.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S678 - S678
  • [25] Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients
    Iwasaki, Y
    Takami, H
    Tani, M
    Yamaguchi, Y
    Goto, H
    Goto, Y
    Goto, Y
    Shigematsu, T
    THERAPEUTIC APHERESIS AND DIALYSIS, 2005, 9 (04) : 347 - 351
  • [26] Efficacy of crushed lanthanum carbonate for hyperphosphatemia in hemodialysis patients undergoing tube feeding
    Kitajima, Yukie
    Takahashi, Taeko
    Sato, Yuzuru
    Nakaya, Yutaka
    CLINICAL KIDNEY JOURNAL, 2011, 4 (04): : 253 - 255
  • [27] Spurious hyperphosphatemia in patients on hemodialysis with catheters
    Schiller, Brigitte
    Virk, Bhupinder
    Blair, Martin
    Wong, Amy
    Moran, John
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (03) : 617 - 620
  • [28] Mild hyperphosphatemia and mortality in hemodialysis patients
    Rodriguez-Benot, A
    Martin-Malo, A
    Alvarez-Lara, MA
    Rodriguez, M
    Aljama, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) : 68 - 77
  • [29] Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study
    Lenglet, Aurelie
    Liabeuf, Sophie
    El Esper, Najeh
    Brisset, Sandrine
    Mansour, Janette
    Lemaire-Hurtel, Anne-Sophie
    Mary, Aurelien
    Brazier, Michel
    Kamel, Said
    Mentaverri, Romuald
    Choukroun, Gabriel
    Fournier, Albert
    Massy, Ziad A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (05) : 870 - 879
  • [30] Efficacy and safety of tenapanor in hemodialysis patients with hyperphosphatemia: A systematic review and meta-analysis of randomized placebo-controlled trials
    Luo, Houli
    Feng, Jian
    Zhang, Yanbiao
    Wang, Jie
    Xue, Gang
    Huang, Xi
    You, Shuang
    Dong, Hongfei
    Li, Lingfan
    Li, Juncheng
    Xiao, Hualin
    Ai, Xiang
    Li, Xianhui
    Huang, Bo
    THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (05) : 839 - 847
12345